Airgain (NASDAQ: AIRG) insider files to sell 1,000 common shares

Rhea-AI Filing Summary

Airgain insider Ali S. Sadri filed a Rule 144 notice to sell 1,000 shares of Airgain common stock. The planned sale through Fidelity Brokerage Services on NASDAQ has an aggregate market value of $5,620.00, with 11,958,193 common shares outstanding.

The shares to be sold come from restricted stock that vested as compensation from the issuer, including 332 shares acquired on 03/15/2025 and 668 shares on 05/15/2025. In the past three months, Sadri has already sold 2,119 shares for $10,615.13 on 02/09/2026 and 881 shares for $4,618.71 on 02/10/2026. By signing the notice, the seller represents they do not know of any material adverse, non-public information about Airgain’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1000	5620.00	11958193	02/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2025	Restricted Stock Vesting	Issuer			332	03/15/2025	Compensation
Common	05/15/2025	Restricted Stock Vesting	Issuer			668	05/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ali S. Sadri 3611 Valley Centre Drive Suite 150 San Diego CA 92130	Common	02/09/2026	2119	10615.13
Ali S. Sadri 3611 Valley Centre Drive Suite 150 San Diego CA 92130	Common	02/10/2026	881	4618.71

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Airgain (AIRG) shares does Ali S. Sadri plan to sell under Rule 144?

Ali S. Sadri plans to sell 1,000 shares of Airgain common stock. The filing lists an aggregate market value of $5,620.00 for this transaction, with the sale to be executed through Fidelity Brokerage Services on the NASDAQ exchange.

When is the planned Rule 144 sale for Airgain (AIRG) shares expected to occur?

The planned sale is targeted for an approximate date of 02/17/2026. The Form 144 specifies this timing for the 1,000-share transaction to be executed through Fidelity Brokerage Services LLC on the NASDAQ market.

How did Ali S. Sadri acquire the Airgain (AIRG) shares being sold?

The shares were acquired through restricted stock vesting as compensation from the issuer. The filing shows 332 shares vested on 03/15/2025 and 668 shares on 05/15/2025, both described as “Compensation” from Airgain.

What recent Airgain (AIRG) stock sales has Ali S. Sadri already completed?

The filing lists two recent sales in the past three months. On 02/09/2026, 2,119 common shares were sold for $10,615.13, and on 02/10/2026, 881 shares were sold for $4,618.71, both by Ali S. Sadri.

How many Airgain (AIRG) common shares are outstanding in this Form 144?

The document reports 11,958,193 Airgain common shares outstanding. This figure provides a baseline for understanding the relative size of the 1,000-share planned sale disclosed in the Rule 144 filing by Ali S. Sadri.

What representation does the seller make in this Airgain (AIRG) Rule 144 notice?

By signing the notice, the seller represents that they do not know any material adverse information about Airgain’s current or prospective operations that has not been publicly disclosed, consistent with the standard representation language included in the form.